ALIVUSNSEAlivus Life Sciences LimitedLowNeutral
Announced Fri, 15 May · 14:25 IST

Alivus Life Sciences Limited has informed the Exchange about Link of Earnings Call Recording

Investor Communications View source PDF

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹1066.00
prior close
₹1040.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.9+0.9+0.8-1.2-0.4-0.4-0.6-2.5+2.1-6.3-1.7+9.9
Up moveDown movePending
AI summary

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has notified exchanges that the audio recording of its Q4 & FY2025-26 Earnings Call held on May 15, 2026 has been uploaded to the company's website. This is a routine regulatory compliance filing under SEBI LODR regulations requiring disclosure of earnings call recordings. The company has provided a direct link to the MP3 audio file on their investor relations portal. The filing was made by the Company Secretary and Compliance Officer.

Likely market impact

This is a standard disclosure filing with no direct impact on stock price. It provides investors access to management commentary on quarterly and annual performance, which investors can review to assess company prospects.